Since leaving the FDA’s top post last January, Steve Hahn has been busy, jumping between multiple industry positions thanks to Flagship Pioneering, and most recently taking the helm at a startup…
The Federal Trade Commission and seven states on Tuesday announced a new order under which the states will recoup $40 million from pharma badboy Martin Shkreli, who’s currently in prison for…
Ophthalmic Sciences’ testing system is housed in a headset similar to those used for virtual reality applications.
Newpath will dole out the $350 million fund to bankroll startups from academic partners at Scripps, Harvard Medical School, Broad Institute, Columbia University and elsewhere. The venture shop will…
Vivo Capital, Bain Capital and Primavera Capital have all come together to place a $200 million-plus bet on lung cancer startup Avistone Pharmaceuticals as it looks to join forces with fellow oncology…
Organizations for LGBTQ+ biopharma employees are popping up in Boston, San Francisco, New York, New Jersey, Dublin and elsewhere. Companies are also working to build up their internal networks as…
Sotio Biotech has advanced its effort to become a major player in the solid tumor space. Days after raising $316 million, Sotio has unveiled a deal with Merck to use Keytruda in a clinical trial that…
With more resources in hand following its October Nasdaq listing, Science 37 has beefed up its presence in the Asia-Pacific region. The latest move sees the hybrid trials provider enter China and…
Merck KGaA is upping its commitment to corporate venture capital with a 600 million euro ($677 million) investment, positioning its VC arm M Ventures to up the number and size of its bets over the…
A Canadian startup aims to give the decades-old, hand-performed ELISA test a 21st century upgrade by transforming the humble immunoassay into a high-throughput protein profiling platform. Formerly…
